Whooping cough: An increasing problem in children and adults in Norway;Kikhoste - Et økende problem i Norge

Tidsskrift for den Norske Laegeforening

Volumn 126, Issue 3, 2006, Pages 305-308

  Dudman, Susanne Gjeruldsen ^a   Trøseid, Marius ^a   Jonassen, Tom Øystein ^a   Steinbakk, Martin ^a  

^a AKERSHUS UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM ANTIBODY; MACROLIDE; PERTUSSIS VACCINE;

ANTIBODY DETECTION; BACTERIAL TRANSMISSION; BACTERIUM CULTURE; BORDETELLA PERTUSSIS; CHILD HOSPITALIZATION; CHILDHOOD MORTALITY; DISEASE COURSE; EXPERIENCE; HUMAN; INFECTION RISK; INFORMATION RETRIEVAL; MEDLINE; NASOPHARYNX; NORWAY; NOSE SECRETION; PARENT; PERTUSSIS; PNEUMONIA; POLYMERASE CHAIN REACTION; REINFECTION; REVIEW; RIB FRACTURE; SCHOOL; SIBLING; SYMPTOM; TREATMENT INDICATION; URINE INCONTINENCE; VACCINATION; VOMITING; ADOLESCENT; ADULT; AGED; CASE REPORT; CHILD; COUGHING; DIFFERENTIAL DIAGNOSIS; DISEASE TRANSMISSION; FEMALE; IMMUNIZATION; MALE;

ADOLESCENT; ADULT; AGED; CHILD; COUGH; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; IMMUNIZATION, SECONDARY; MALE; NORWAY; PERTUSSIS VACCINE; WHOOPING COUGH;

EID: 33644871182     PISSN: 00292001     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (26)

1. Trøseid M, Jonassen TØ, Steinbakk M. Isolation of Bordetella pertussis in blood culture from a patient with multiple myeloma. J Infect 2005. E-publisert 1.6.2005.
2. Bordet J, Gengou U. Le microbe de la coqueluche. Ann Inst Pasteur 1906; 20: 48-68.
3. Crowcroft NS, Stein C, Duclos P et al. How best to estimate the global burden of pertussis? Lancet Infect Dis 2003; 3: 413-8.
4. World Health Organization. Expanded programme on immunization. Global Advisory Group Meeting, 14-18 October, Antalya, Turkey. Report No. 49. Genève: WHO, 1992.
5. Nasjonalt folkehelseinstitutt. Kikhoste (pertussis). www.fhi.no (14.6.2005).
6. Mattoo S, Cherry JD. Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies. Clin Microbiol Rev 2005; 18: 326-82.
7. Heininger U, Stehr K, Schmitt-Grohe S et al. Clinical characteristics of illness caused by Bordetella parapertussis compared with illness caused by Bordetella pertussis. Pediatr Infect Dis J 1994; 13: 306-9.
8. Cherry JD. Historical review of pertussis and the classical vaccine. J Infect Dis 1996; 174: S259-S263.
9. Schellekens J, von Konig CH, Gardner P. Pertussis sources of infection and routes of transmission in the vaccination era. Pediatr Infect Dis J 2005; 24: S19-S24.
10. Edwards KM. Is pertussis a frequent cause of cough in adolescents and adults? Should routine pertussis immunization be recommended? Clin Infect Dis 2001; 15: 1698-9.
11. Heininger U, Cherry JD, Eckhardt T et al. Clinical and laboratory diagnosis of pertussis in the regions of a large vaccine efficacy trial in Germany. Pediatr Infect Dis J 1993; 12: 504-9.
12. Schlapfer G, Cherry JD, Heininger U et al. Polymerase chain reaction identification of Bordetella pertussis infections in vaccinees and family members in a pertussis vaccine efficacy trial in Germany. Pediatr Infect Dis J 1995; 14: 209-14.
13. Heininger U, Stehr K, Cherry JD. Serious pertussis overlooked in infants. Eur J Pediatr 1992; 151: 342-3.
14. Greenberg DP, von Konig CH, Heininger U. Health burden of pertussis in infants and children. Pediatr Infect Dis J 2005; 24: S39-S43.
15. Postels-Multani S, Schmitt HJ, Wirsing von Konig CH et al. Symptoms and complications of pertussis in adults. Infection 1995; 23: 139-42.
16. Rothstein E, Edwards K. Health burden of pertussis in adolescents and adults. Pediatr Infect Dis J 2005; 24: S44-S47.
17. World Health Organization. Pertussis surveillance: Global meeting, October 16-18, 2000. WHO/V&B/01. Report No.19. Genève: WHO, 2000.
18. Muller FM, Hoppe JE, Wirsing von Konig CH. Laboratory diagnosis of pertussis: state of the art in 1997. J Clin Microbiol 1997; 35: 2435-43.
19. Povitsky OR, Worth E. Agglutination in pertussis: its characteristics and its comparative value in clinical diagnosis, and in determination of genus and species. Arch Intern Med 1916; 17: 279-92.
20. Cherry JD, Grimprel E, Guiso N et al. Defining pertussis epidemiology: clinical, microbiologic and serologic perspectives. Pediatr Infect Dis J 2005; 24: S25-S34.
21. de Melker HE, Versteegh FG, Conyn-van Spaendonck MA et al. Specificity and sensitivity of high levels of immunoglobulin G antibodies against pertussis toxin in a single serum sample for diagnosis of infection with Bordetella pertussis. J Clin Microbiol 2000; 38: 800-6.
22. Loeffelholz MD. Bordetella. I: Murray PR, red. Manual of clinical microbiology. American Society for Microbiology. Washington D.C.: ASM Press, 2003: 780-8.
23. Wirsing von Konig CH. Use of antibiotics in the prevention and treatment of pertussis. Pediatr Infect Dis J 2005; 24, S66-S68.
24. Wendelboe AM, Van RA, Salmaso S et al. Duration of immunity against pertussis after natural infection or vaccination. Pediatr Infect Dis J 2005; 24: S58-S61.
25. Tan T, Trindade E, Skowronski D. Epidemiology of pertussis. Pediatr Infect Dis J 2005; 24: S10-S18.
26. Vaksinasjon mot kikhoste: Innføring av ny boosterdose i barnevaksinasjonsprogrammet. MSIS-rapport 2005; 33: 24.